Kronos Bio, Inc. Annual Operating Lease, Payments in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Kronos Bio, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2018 to 2023.
  • Kronos Bio, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $1.9M, a 46.2% increase year-over-year.
  • Kronos Bio, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $6.3M, a 18.9% increase year-over-year.
  • Kronos Bio, Inc. annual Operating Lease, Payments for 2023 was $5.6M, a 1.75% decline from 2022.
  • Kronos Bio, Inc. annual Operating Lease, Payments for 2022 was $5.7M, a 29.5% increase from 2021.
  • Kronos Bio, Inc. annual Operating Lease, Payments for 2021 was $4.4M, a 57.1% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.6M -$100K -1.75% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $5.7M +$1.3M +29.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $4.4M +$1.6M +57.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 $2.8M +$2.5M +833% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $300K +$100K +50% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 $200K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.